FMR LLC Reports 10.2% Stake in Charles River Laboratories
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Subscribe to track CRL
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Institutional Holding Update: FMR LLC has filed an amended Schedule 13G/A reporting beneficial ownership of 4,865,628.13 shares (10.2%) of Charles River Laboratories International, Inc. ($CRL) as of August 31, 2026.
Comprehensive Analysis
Beneficial Ownership Update: FMR LLC & Charles River Laboratories International, Inc.
Overview
On September 8, 2026, FMR LLC filed Amendment No. 2 to Schedule 13G regarding its stake in Charles River Laboratories International, Inc. ($CRL) with an event date of August 31, 2026.
Key Position Details
- Reporting Persons: FMR LLC, Abigail P. Johnson
- Security: Common Stock (CUSIP: 159864107)
- Aggregate Beneficial Ownership: 4,865,628.13 shares
- Percentage of Class: 10.2%
- Voting Power: Sole voting power over 4,813,779.74 shares; shared voting power over 0 shares
- Dispositive Power: Sole dispositive power over 4,865,628.13 shares; shared dispositive power over 0 shares
Context & Filing Reason
Filed under Rule 13d-1(b) as a passive institutional investor holding more than 10% of the class. Key operating subsidiaries include Fidelity Management & Research Company LLC (which beneficially owns 5% or greater of the outstanding shares), FIAM LLC, and Strategic Advisers LLC.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.
The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.
Always do your own due diligence and consult a licensed professional.
